|
02 Jan 2021 |
EpiVax and EpiVax Therapeutics Advance COVID-19 Vaccine Program, EPV-CoV-19
|
|
02 Jan 2021 |
Moderna Announces Publication of Results from the Pivotal Phase 3 Trial of the Moderna COVID-19 Vaccine in The New England Journal of Medicine
|
|
30 Dec 2020 |
AstraZeneca’s COVID-19 vaccine authorised for emergency supply in the UK
|
|
29 Dec 2020 |
Novavax Announces Initiation of PREVENT-19 Pivotal Phase 3 Efficacy Trial of COVID-19 Vaccine in the United States and Mexico
|
|
29 Dec 2020 |
IMV Reports Update on COVID-19 Vaccine Program
|
|
29 Dec 2020 |
Arcturus Therapeutics Received Approval from Singapore Health Sciences Authority to Proceed with Phase 2 Study of ARCT-021 (LUNAR-COV19) Vaccine Candidate and Provides New and Updated Clinical and Preclinical Data
|
|
24 Dec 2020 |
Altimmune Provides an Update on its Investigational New Drug Application for a Phase 1 AdCOVID™ Clinical Trial
|
|
24 Dec 2020 |
Aurobindo Pharma and COVAXX Sign an Exclusive Agreement to Develop and Commercialize COVID-19 Vaccine UB-612 for India and UNICEF
|
|
23 Dec 2020 |
Serum Institute Of India And Dynavax Announce First Participants Dosed In The Phase 1/2 Clinical Trial For A COVID-19 Vaccine
|
|
23 Dec 2020 |
Ocugen and Bharat Biotech to Co-Develop COVAXIN™, a Whole-Virion Inactivated COVID-19 Vaccine, for the US Market
|
|
23 Dec 2020 |
Evaxion Biotech Doses First Patient in Phase I/IIa Melanoma Trial of Cancer Vaccine EVX-02 in Combination With Checkpoint Inhibitors
|
|
23 Dec 2020 |
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine
|
|
22 Dec 2020 |
Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine
|
|
22 Dec 2020 |
Ultimovacs ASA Initiates FOCUS Phase II Trial for Universal Cancer Vaccine, UV1, in Head and Neck Cancer Patients Receiving Pembrolizumab
|
|
21 Dec 2020 |
Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine
|
|
19 Dec 2020 |
Moderna Announces FDA Authorization of Moderna COVID-19 Vaccine in U.S.
|
|
18 Dec 2020 |
Enesi Pharma and Imperial College London Collaborate to Develop Thermostable RNA Vaccines with Potential to Eliminate Cold Chain and Transform Global Vaccination Logistics for COVID-19
|
|
18 Dec 2020 |
Moderna Receives FDA Advisory Committee Vote Supporting Emergency Use for Moderna’s Vaccine Against COVID-19 in the United States
|
|
17 Dec 2020 |
CureVac Commences Global Pivotal Phase 2b/3 Trial for COVID-19 Vaccine Candidate, CVnCoV
|
|
16 Dec 2020 |
Valneva Initiates Phase 1/2 Clinical Study of Inactivated, Adjuvanted COVID-19 Vaccine Candidate
|
|
16 Dec 2020 |
Provention Bio Initiates First-in-Human Study of Coxsackievirus B Vaccine Candidate PRV-101
|
|
16 Dec 2020 |
The Food and Drug Administration (FDA) grants IO Biotech breakthrough therapy designation for IO102 and IO103 in combination with anti-PD-1 in unresectable/ metastatic melanoma
|
|
14 Dec 2020 |
Pfizer and BioNTech Provide Data from German Phase 1/2 Study Further Characterizing Immune Response Following Immunization with Lead COVID-19 Vaccine Candidate BNT162b2
|
|
14 Dec 2020 |
Codagenix and Serum Institute of India Announce Commencement of First-in-Human Trial of COVI-VAC, A Single Dose, Intranasal Live Attenuated Vaccine for COVID-19
|
|
14 Dec 2020 |
ImmunoPrecise and LiteVax Advance SARS-CoV-2 Vaccine Candidate
|
